Terminated NA INTERVENTIONAL NCT00282139

Aripiprazole in the Treatment of Tourette's Syndrome

Sponsor: Bristol-Myers Squibb

Updated 6 times since 2017 Last updated: Oct 4, 2011 Started: Jan 31, 2004 Primary completion: Oct 31, 2006 Completion: Oct 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Bristol-Myers Squibb

See all terminations from Bristol-Myers Squibb

A NA clinical study on Tourette's Syndrome, this trial is terminated or withdrawn. The trial is conducted by Bristol-Myers Squibb and has accumulated 6 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Feb 2017 — Jun 2018 [monthly]

Terminated NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bristol-Myers Squibb
University of Florida

Data source: University of Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gainesville, United States